Design Therapeutics, Inc. (DSGN) Ownership

$6.11

north_east
$0.1 (1.58%)
Day's range
$5.88
Day's range
$6.21

Design Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
SR ONE CAPITAL MANAGEMENT, LP 11/12/2025 6.53 M $49.14 M   0.00% 11.48%
LOGOS GLOBAL MANAGEMENT LP 11/14/2025 3.66 M $27.52 M   -13.34% 6.43%
POINT72 ASSET MANAGEMENT, L.P. 11/14/2025 3.34 M $25.15 M   84.85% 5.88%
BLACKROCK, INC. 11/12/2025 2.04 M $15.39 M   -14.67% 3.60%
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. 11/14/2025 1.95 M $14.71 M   0.00% 3.44%
TANG CAPITAL MANAGEMENT LLC 11/14/2025 1.78 M $13.41 M   0.00% 3.13%
BAKER BROS. ADVISORS LP 11/14/2025 1.71 M $12.90 M   0.00% 3.01%
ALMITAS CAPITAL LLC 11/17/2025 1.53 M $11.52 M   0.00% 2.69%
VANGUARD GROUP INC 11/07/2025 1.44 M $10.87 M   -1.89% 2.54%
DRIEHAUS CAPITAL MANAGEMENT LLC 11/14/2025 1.08 M $8.10 M   0.00% 1.89%
KYNAM CAPITAL MANAGEMENT, LP 11/14/2025 1.03 M $7.75 M   0.00% 1.81%
FMR LLC 11/13/2025 740.85 K $5.58 M   -22.11% 1.30%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 695.61 K $5.24 M   -12.39% 1.22%
STATE STREET CORP 11/14/2025 634.40 K $4.78 M   -11.79% 1.12%
ACADIAN ASSET MANAGEMENT LLC 11/13/2025 617.49 K $4.65 M   -1.57% 1.09%
WOODLINE PARTNERS LP 11/14/2025 612.71 K $4.61 M   -21.20% 1.08%
BIOIMPACT CAPITAL LLC 11/14/2025 555.19 K $4.18 M   0.00% 0.98%
CITADEL ADVISORS LLC 11/14/2025 554.02 K $4.17 M   -34.11% 0.97%
RA CAPITAL MANAGEMENT, L.P. 11/14/2025 475.70 K $3.58 M   100.00% 0.84%
D. E. SHAW & CO., INC. 11/14/2025 373.28 K $2.81 M   -4.45% 0.66%
NORTHERN TRUST CORP 11/14/2025 296.53 K $2.23 M   -18.20% 0.52%
DIMENSIONAL FUND ADVISORS LP 11/12/2025 279.82 K $2.11 M   -10.71% 0.49%
RENAISSANCE TECHNOLOGIES LLC 11/13/2025 274.30 K $2.07 M   2.43% 0.48%
GOLDMAN SACHS GROUP INC 11/14/2025 261.45 K $1.97 M   9.18% 0.46%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 247.93 K $1.87 M   -1.20% 0.44%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 11/14/2025 188.20 K $1.42 M   0.00% 0.33%
MORGAN STANLEY 11/14/2025 175.99 K $1.33 M   -17.59% 0.31%
NUVEEN, LLC 11/12/2025 133.03 K $1.00 M   0.00% 0.23%
JANE STREET GROUP, LLC 11/14/2025 117.83 K $887.28 K   279.14% 0.21%
BARCLAYS PLC 11/12/2025 88.18 K $663.97 K   -19.50% 0.16%
BANK OF NEW YORK MELLON CORP 11/03/2025 87.48 K $658.69 K   -7.53% 0.15%
MILLENNIUM MANAGEMENT LLC 11/14/2025 68.82 K $518.24 K   100.00% 0.12%
LYNX1 CAPITAL MANAGEMENT LP 11/13/2025 65.95 K $496.63 K   0.00% 0.12%
TWO SIGMA INVESTMENTS, LP 11/14/2025 59.24 K $446.06 K   -33.67% 0.10%
PALUMBO WEALTH MANAGEMENT LLC 11/10/2025 52.08 K $392.17 K   -13.99% 0.09%
AMERICAN CENTURY COMPANIES INC 11/12/2025 50.85 K $382.92 K   9.63% 0.09%
DLD ASSET MANAGEMENT, LP 11/14/2025 50.00 K $376.50 K   100.00% 0.09%
RHUMBLINE ADVISERS 11/06/2025 46.33 K $348.89 K   -4.10% 0.08%
ALLIANCEBERNSTEIN L.P. 11/14/2025 46.12 K $347.28 K   2.42% 0.08%
PRUDENTIAL FINANCIAL INC 11/13/2025 44.83 K $337.53 K   -22.62% 0.08%
TWO SIGMA ADVISERS, LP 11/14/2025 40.50 K $304.97 K   -62.67% 0.07%
CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. 11/10/2025 34.98 K $263.41 K   206.81% 0.06%
HRT FINANCIAL LP 11/14/2025 31.90 K $240.00 K   100.00% 0.06%
KENNEDY CAPITAL MANAGEMENT LLC 11/13/2025 29.41 K $221.47 K   95.94% 0.05%
STATE OF WISCONSIN INVESTMENT BOARD 11/14/2025 27.06 K $203.78 K   -5.58% 0.05%
BANK OF AMERICA CORP /DE/ 11/14/2025 23.91 K $180.02 K   -2.92% 0.04%
JPMORGAN CHASE & CO 11/26/2025 23.22 K $174.85 K   26.72% 0.04%
UBS GROUP AG 11/13/2025 22.69 K $170.88 K   -17.00% 0.04%
STRS OHIO 10/30/2025 22.60 K $170.18 K   0.00% 0.04%
SPHERA FUNDS MANAGEMENT LTD. 11/14/2025 21.92 K $165.04 K   100.00% 0.04%

Design Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 171 institutional investors and hedge funds held shares of Design Therapeutics, Inc.. The most heavily invested institutionals were:

SR ONE CAPITAL MANAGEMENT, LP: 6.53 M

Logos Global Management LP: 3.66 M

Point72 Asset Management, L.P.: 3.34 M

BlackRock, Inc.: 2.04 M

Frazier Life Sciences Management, L.P.: 1.95 M

TANG CAPITAL MANAGEMENT LLC: 1.78 M

60.66% of Design Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 44.01 M shares in the last 24 months. This purchase volume represents approximately $268.90 M in transactions.